Abstract
Since the first clinical simultaneous positron emission tomography/magnetic resonance imaging (PET/MR) units were developed in 2010 as predominantly research tools, PET/MR has been frequently utilized in clinical practice for the evaluation of neurological diseases, including brain tumors, neurodegenerative disorders, and epilepsy as well as head and neck cancers. Compared to PET/CT, PET/MR has the inherent advantages of MRI, including superior tissue contrast, capability of multiparametric images, and lack of ionizing radiation. Also, a single-session PET/MR reduces the transportation time between examination rooms, and for pediatric patients, it reduces the risk of sedation. However, there are also several disadvantages when shifting from PET/CT to PET/MR as follows:
-
1.
Scan time. Although PET/MR reduces the number of imaging sessions, the average scan time of PET/MR (~1Â h) is longer than that of PET/CT (30 mins) leading to a higher chance of motion artifacts and requiring sedation in pediatric patients.
-
2.
Quantitative accuracy. Quantitative accuracy in PET relies on accurate attenuation correction (AC) maps and motion correction. AC is known as a challenge in PET/MR because there is no direct relationship between the PET attenuation coefficients and the intensity of the MR signal contrary to PET/CT.
Here we address recent advances in PET/MR in the evaluation of several neurological disorders. First, we discuss how recent major technological advances and trends provide solutions to the above issues. Second, we discuss recent progresses of artificial intelligence (AI) in coping with two common challenges in multi-modal imaging research: missing data and representation of multi-modal data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Surti S, Karp JS. Current status of PET technology. In: Zhang J, Knopp MV, editors. Advances in PET: the latest in instrumentation, technology, and clinical practice. Cham: Springer International Publishing; 2020. p. 3–14.
Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.
Tan H, Gu Y, Yu H, Hu P, Zhang Y, Mao W, et al. Total-body PET/CT: current applications and future perspectives. AJR Am J Roentgenol. 2020;215(2):325–37.
Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59(1):3–12.
Ordonez AA, Sellmyer MA, Gowrishankar G, Ruiz-Bedoya CA, Tucker EW, Palestro CJ, et al. Molecular imaging of bacterial infections: overcoming the barriers to clinical translation. Sci Transl Med. 2019;11(508):eaax8251.
Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, et al. Decreased nicotinic receptor availability in smokers with slow rates of nicotine metabolism. J Nucl Med. 2015;56(11):1724–9.
Cavaliere C, Tramontano L, Fiorenza D, Alfano V, Aiello M, Salvatore M. Gliosis and neurodegenerative diseases: the role of PET and MR imaging. Front Cell Neurosci. 2020;14:75.
Vandenberghe S, Mikhaylova E, D’Hoe E, Mollet P, Karp JS. Recent developments in time-of-flight PET. EJNMMI Phys. 2016;3(1):3.
Yamaguchi S, Wagatsuma K, Miwa K, Ishii K, Inoue K, Fukushi M. Bayesian penalized-likelihood reconstruction algorithm suppresses edge artifacts in PET reconstruction based on point-spread-function. Phys Med. 2018;47:73–9.
Beyer T, Lassen ML, Boellaard R, Delso G, Yaqub M, Sattler B, et al. Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems. MAGMA. 2016;29(1):75–87.
Chen Y, An H. Attenuation correction of PET/MR imaging. Magn Reson Imaging Clin N Am. 2017;25(2):245–55.
Sekine T, Buck A, Delso G, Ter Voert EE, Huellner M, Veit-Haibach P, et al. Evaluation of atlas-based attenuation correction for integrated PET/MR in human brain: application of a head atlas and comparison to true CT-based attenuation correction. J Nucl Med. 2016;57(2):215–20.
Sekine T, Ter Voert EE, Warnock G, Buck A, Huellner M, Veit-Haibach P, et al. Clinical evaluation of zero-Echo-time attenuation correction for brain 18F-FDG PET/MRI: comparison with atlas attenuation correction. J Nucl Med. 2016;57(12):1927–32.
Wiesinger F, Bylund M, Yang J, Kaushik S, Shanbhag D, Ahn S, et al. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning. Magn Reson Med. 2018;80(4):1440–51.
Mackewn JE, Stirling J, Jeljeli S, Gould SM, Johnstone RI, Merida I, et al. Practical issues and limitations of brain attenuation correction on a simultaneous PET-MR scanner. EJNMMI Phys. 2020;7(1):24.
Inomata T, Watanuki S, Odagiri H, Nambu T, Karakatsanis NA, Ito H, et al. A systematic performance evaluation of head motion correction techniques for 3 commercial PET scanners using a reproducible experimental acquisition protocol. Ann Nucl Med. 2019;33(7):459–70.
Catana C, Benner T, van der Kouwe A, Byars L, Hamm M, Chonde DB, et al. MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner. J Nucl Med. 2011;52(1):154–61.
Gillman A, Smith J, Thomas P, Rose S, Dowson N. PET motion correction in context of integrated PET/MR: current techniques, limitations, and future projections. Med Phys. 2017;44(12):e430–e45.
Slipsager JM, Ellegaard AH, Glimberg SL, Paulsen RR, Tisdall MD, Wighton P, et al. Markerless motion tracking and correction for PET, MRI, and simultaneous PET/MRI. PLoS One. 2019;14(4):e0215524.
Kyme AZ, Aksoy M, Henry DL, Bammer R, Maclaren J. Marker-free optical stereo motion tracking for in-bore MRI and PET-MRI application. Med Phys. 2020;47(8):3321–31.
Zaharchuk G. Next generation research applications for hybrid PET/MR and PET/CT imaging using deep learning. Eur J Nucl Med Mol Imaging. 2019;46(13):2700–7.
Gong K, Yang J, Kim K, El Fakhri G, Seo Y, Li Q. Attenuation correction for brain PET imaging using deep neural network based on Dixon and ZTE MR images. Phys Med Biol. 2018;63(12):125011.
Wang Y, Yu B, Wang L, Zu C, Lalush DS, Lin W, et al. 3D conditional generative adversarial networks for high-quality PET image estimation at low dose. Neuroimage. 2018;174:550–62.
Xiang L, Qiao Y, Nie D, An L, Wang Q, Shen D. Deep auto-context convolutional neural networks for standard-dose PET image estimation from low-dose PET/MRI. Neurocomputing. 2017;267:406–16.
Wang Y, Shen D, Ma G, An L, Shi F, Zhang P, et al. Semisupervised tripled dictionary learning for standard-dose PET image prediction using low-dose PET and multimodal MRI. IEEE Trans Biomed Eng. 2017;64(3):569–79.
Xu J, Gong E, Ouyang J, Pauly J, Zaharchuk G. Ultra-low-dose 18F-FDG brain PET/MR denoising using deep learning and multi-contrast information: SPIE; 2020.
Liu M, Zhang J, Yap PT, Shen D. View-aligned hypergraph learning for Alzheimer’s disease diagnosis with incomplete multi-modality data. Med Image Anal. 2017;36:123–34.
Parker R. Missing data problems in machine learning: VDM Verlag; 2010.
Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, et al. The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27(4):685–91.
Liu M, Zhang J, Adeli E, Shen D. Landmark-based deep multi-instance learning for brain disease diagnosis. Med Image Anal. 2018;43:157–68.
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
Zhu J-Y, Park T, Isola P, Efros AA, editors. Unpaired image-to-image translation using cycle-consistent adversarial networks. IEEE; 2017.
Beckmann M, Lloyd AJ, Haldar S, Fave G, Seal CJ, Brandt K, et al. Dietary exposure biomarker-lead discovery based on metabolomics analysis of urine samples. Proc Nutr Soc. 2013;72(3):352–61.
Krizhevsky A, Sutskever I, Hinton GE, editors. ImageNet classification with deep convolutional neural networks. NIPS; 2012.
Liu M, Zhang J, Nie D, Yap PT, Shen D. Anatomical landmark based deep feature representation for MR images in brain disease diagnosis. IEEE J Biomed Health Inform. 2018;22(5):1476–85.
Pan Y, Liu M, Lian C, Xia Y, Shen D. Spatially-constrained fisher representation for brain disease identification with incomplete multi-modal neuroimages. IEEE Trans Med Imaging; 2020.
Pan Y, Liu M, Lian C, Zhou T, Xia Y, Shen D, editors. Synthesizing missing PET from MRI with cycle-consistent generative adversarial networks for Alzheimer’s disease diagnosis. Cham: Springer International Publishing; 2018.
Lian C, Liu M, Zhang J, Shen D. Hierarchical fully convolutional network for joint atrophy localization and Alzheimer's disease diagnosis using structural MRI. IEEE Trans Pattern Anal Mach Intell. 2020;42(4):880–93.
Cheng B, Liu M, Zhang D, Munsell BC, Shen D. Domain transfer learning for MCI conversion prediction. IEEE Trans Biomed Eng. 2015;62(7):1805–17.
Wachinger C, Salat DH, Weiner M, Reuter M. Alzheimer’s disease neuroimaging I. Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala. Brain. 2016;139(Pt 12):3253–66.
Zhang D, Shen D. Alzheimer’s disease neuroimaging I. Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer’s disease. Neuroimage. 2012;59(2):895–907.
Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert MO, et al. Automatic classification of patients with Alzheimer’s disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage. 2011;56(2):766–81.
Pan Y, Liu M, Lian C, Xia Y, Shen D, editors. Disease-image specific generative adversarial network for brain disease diagnosis with incomplete multi-modal neuroimages. Cham: Springer International Publishing; 2019.
Hore A, Ziou D, editors. Image quality metrics: PSNR vs. SSIM. IEEE; 2010.
Zhang J, Liu M, Pan Y, Shen D. Unsupervised conditional consensus adversarial network for brain disease identification with structural MRI. Cham: Springer International Publishing; 2019.
Wang M, Zhang D, Huang J, Yap PT, Shen D, Liu M. Identifying autism spectrum disorder with multi-site fMRI via low-rank domain adaptation. IEEE Trans Med Imaging. 2020;39(3):644–55.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hung, SC., Liu, M., Yap, PT., Shen, D., Lin, W., Castillo, M. (2022). Future Trends of PET/MR and Utility of AI in Multi-Modal Imaging. In: Franceschi, A.M., Franceschi, D. (eds) Hybrid PET/MR Neuroimaging. Springer, Cham. https://doi.org/10.1007/978-3-030-82367-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-82367-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-82366-5
Online ISBN: 978-3-030-82367-2
eBook Packages: MedicineMedicine (R0)